NCT03070054View on ClinicalTrials.gov

LIA in Hip Arthroscopy Patients

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions
Pain
Interventions
DRUG

20ml 0.25% bupivacaine-epinephrine

Extra-capsular local infiltration analgesic (LIA) administration of 20ml 0.25% bupivacaine-epinephrine

Trial Locations (1)

84108

University of Utah Orthopaedic Center, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT03070054 - LIA in Hip Arthroscopy Patients | Biotech Hunter | Biotech Hunter